Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease
Clinical trial NCT04358081 · COMPLETED
Trial details
- NCT number
- NCT04358081
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-07-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.